Nasdaq-listed Sonnet BioTherapeutics agrees to $888 million merger to become Hyperliquid Strategies, launch HYPE treasury – The Block

  1. Nasdaq-listed Sonnet BioTherapeutics agrees to $888 million merger to become Hyperliquid Strategies, launch HYPE treasury  The Block
  2. Massive $888M Deal: Biotech Firm Makes Historic Pivot to Become Largest US Public HYPE Token Holder  Stock Titan
  3. Sonnet BioTherapeutics jumps over 320%, combines business for HYPE crypto reserve (SONN:NASDAQ)  Seeking Alpha
  4. Sonnet BioTherapeutics, Inc. Announces $888 Million  GlobeNewswire
  5. Why Is Sonnet BioTherapeutics Stock (SONN) Up 180% Today?  TipRanks

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *